Non Hodgkin Lymphoma Clinical Trial

Clinical Trial Finder Non Hodgkin Lymphoma Trials

Dose-escalation Study of Safety of PBCAR19B in Participants With CD19-expressing Malignancies

See Locations Near You

Summary

This is a Phase 1, nonrandomized, open-label, single-dose, dose-escalation, and dose-expansion study to evaluate the safety and clinical activity of PBCAR19B in adult study participants with CD-19 expressing malignancies.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Relapsed or refractory CD19+ expressing malignancies
At least 2 prior regimens per Standard of Care

Exclusion Criteria:

No history of active CNS involvement

Study is for people with:

Non Hodgkin Lymphoma

Phase:

Phase 1

Estimated Enrollment:

24

Study ID:

NCT04649112

Recruitment Status:

Recruiting

Sponsor:

Precision BioSciences, Inc.

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 7 Locations for this study

See Locations Near You

Banner MDA
Gilbert Arizona, 85234, United States More Info
Rajneesh Nath, MD
Contact
Rajneesh Nath, MD
Principal Investigator
City of Hope
Duarte California, 91010, United States More Info
Alex Herrera, MD
Contact
Alex Herrera, MD
Principal Investigator
Moffitt Cancer Center
Tampa Florida, 33612, United States More Info
Michael Jain, MD
Contact
Michael Jain, MD
Principal Investigator
Tufts Medical Center
Boston Massachusetts, 02111, United States More Info
Andreas Klein, MD
Contact
Andreas Klein, MD
Principal Investigator
Columbia University
New York New York, 10032, United States More Info
Ran Reshef, MD
Contact
Ran Reshef, MD
Principal Investigator
Thomas Jefferson University
Philadelphia Pennsylvania, 19107, United States More Info
Usama Gergis, MD
Contact
Usama Gergis, MD
Principal Investigator
Lifespan Cancer Institute at Rhode Island Hospital
Providence Rhode Island, 02903, United States More Info
Adam Olszewski, MD
Contact
Adam Olszewski, MD
Principal Investigator
Load More

How clear is this clinincal trial information?

Study is for people with:

Non Hodgkin Lymphoma

Phase:

Phase 1

Estimated Enrollment:

24

Study ID:

NCT04649112

Recruitment Status:

Recruiting

Sponsor:


Precision BioSciences, Inc.

How clear is this clinincal trial information?

Clinical Trial Resources

Why I’d Choose a Clinical Trial For Myself
Clinical Trials Can be Life-Saving for Some
Clinical Trials Test State-of-the-Art Cancer Treatments
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider